Phytotherapy, drug regulation

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 25.01.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The monographs of the German Commission E have worldwide significance. According to §25 AMG 76, Commission E consists of 24 experts who must demonstrate special knowledge - scientific and/or practical - about the phytotherapeutic therapy direction and substance group.
The result of the factual discussions, in which the professional societies or individual scientists could also intervene, was laid down in positive and negative monographs published in the Federal Gazette. Internationally active expert groups dealing with phytotherapeutic therapy directions and substance groups are:

The monographs provide detailed information on the drugs used and their ingredients, and present the results from available pharmacological, pharmacokinetic, toxicological, and clinical studies.

LiteratureThis section has been translated automatically.

  1. Krenn L (2013)ESCOP on-line: new monographs available! Phytomedicines 20:469.

Authors

Last updated on: 25.01.2022